Literature DB >> 19925903

Hepatitis A and E: update on prevention and epidemiology.

David FitzSimons1, Greet Hendrickx, Alex Vorsters, Pierre Van Damme.   

Abstract

In March 2009 the Viral Hepatitis Prevention Board (VHPB) organized a meeting in Antwerp, in order to review the status of epidemiology and prevention of both hepatitis A and E. International hepatitis experts from the public health and academic sector provided the state of the art on HAV and emphasized the growing public health importance of the disease, in particular in intermediate endemicity regions, and the need for control at global level. The information shared on HEV showed clearly that it is emerging, but still a lot of efforts are needed to clarify among others the transmission routes, the clinical presentations and the burden of disease. First data on hepatitis E vaccines were discussed, showing a promising safety and efficacy profile. The meeting was concluded with lessons learnt, challenges, needs and proposed step forwards for both diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19925903     DOI: 10.1016/j.vaccine.2009.10.136

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  30 in total

1.  Multicentric evaluation of new commercial enzyme immunoassays for the detection of immunoglobulin M and total antibodies against hepatitis A virus.

Authors:  M C Arcangeletti; E Dussaix; F Ferraglia; A M Roque-Afonso; A Graube; C Chezzi
Journal:  Clin Vaccine Immunol       Date:  2011-06-08

2.  Determining the persistence of maternally acquired antibodies to hepatitis A and varicella zoster during the first 2 years of life in Turkey.

Authors:  Fırat Begde; Filiz Simsek Orhon; Devran Gerceker; Betul Ulukol; Seda Topcu; Sevgi Baskan
Journal:  Eur J Pediatr       Date:  2015-01-07       Impact factor: 3.183

3.  Hepatitis E virus and hepatitis A virus exposures in an apparently healthy high-risk population in Italy.

Authors:  M Rapicetta; R Monarca; L A Kondili; P Chionne; E Madonna; G Madeddu; A Soddu; A Candido; S Carbonara; M S Mura; G Starnini; S Babudieri
Journal:  Infection       Date:  2012-12-22       Impact factor: 3.553

4.  Effectiveness of hepatitis A vaccination as post-exposure prophylaxis.

Authors:  Ignasi Parrón; Caritat Planas; Pere Godoy; Sandra Manzanares-Laya; Ana Martínez; Maria Rosa Sala; Sofia Minguell; Nuria Torner; Mireia Jané; Angela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2016-12-07       Impact factor: 3.452

5.  Effectiveness of 10-year vaccination (2001-2010) on Hepatitis A in Tianjin, China.

Authors:  Zhi-lun Zhang; Xiang-jun Zhu; Ai-lan Shan; Zhi-gang Gao; Ying Zhang; Ya-xing Ding; Hui Liu; Wei-shen Wu; Yong Liu; Hai-yan He; Xiao-hua Xie; Wei-dong Xia; Chao Li; Wen-ti Xu; Zhi-yuan Li; Hua-liang Lin; Wei-ming Fu
Journal:  Hum Vaccin Immunother       Date:  2014-02-06       Impact factor: 3.452

6.  High Prevalence of Symptomatic Hepatitis A Infection in Rural Area of Chaharmahal VA Bakhtiari Province, Iran.

Authors:  Ali Karimi; Seifollah Mortazaei; Mohammad-Taghi Moradi
Journal:  J Clin Diagn Res       Date:  2015-02-01

7.  Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination.

Authors:  Eduardo Lazcano-Ponce; Carlos Conde-Gonzalez; Rosalba Rojas; Rodrigo DeAntonio; Luis Romano-Mazzotti; Yolanda Cervantes; Eduardo Ortega-Barria
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

8.  Hepatitis A: Epidemiology and prevention in developing countries.

Authors:  Elisabetta Franco; Cristina Meleleo; Laura Serino; Debora Sorbara; Laura Zaratti
Journal:  World J Hepatol       Date:  2012-03-27

9.  Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha.

Authors:  Lingli Yang; Tomoko Kiyohara; Tatsuo Kanda; Fumio Imazeki; Keiichi Fujiwara; Verena Gauss-Müller; Koji Ishii; Takaji Wakita; Osamu Yokosuka
Journal:  Virol J       Date:  2010-09-03       Impact factor: 4.099

10.  Clinical and laboratory features of viral hepatitis A in children.

Authors:  Zuzana Blechová; Milan Trojánek; Jan Kynčl; Jitka Cástková; Jerry John; Marek Malý; Kristýna Herrmannová; Vilma Marešová
Journal:  Wien Klin Wochenschr       Date:  2013-01-29       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.